India  

FDA Warns Companies to Stop Selling Potentially Dangerous, Unapproved Eye Drops

Video Credit: Wibbitz Top Stories - Duration: 01:30s - Published
FDA Warns Companies to Stop Selling Potentially Dangerous, Unapproved Eye Drops

FDA Warns Companies to Stop Selling Potentially Dangerous, Unapproved Eye Drops

FDA Warns Companies to, Stop Selling Potentially Dangerous, , Unapproved Eye Drops.

Gizmodo reports that the United States Food and Drug Administration (FDA) has warned several companies to stop selling unapproved eye drop products.

On September 12, the FDA announced that it had issued warning letters to eight companies regarding the potentially dangerous products.

The companies, including major retail chains CVS and Walgreens, have allegedly committed a number of violations by marketing or manufacturing these products.

The companies, including major retail chains CVS and Walgreens, have allegedly committed a number of violations by marketing or manufacturing these products.

The companies, including major retail chains CVS and Walgreens, have allegedly committed a number of violations by marketing or manufacturing these products.

The FDA has also expressed concerns over silver compounds found in some of the products, which can turn people's skin or eyes blue with long-term use.

According to the FDA, some of the eye drop products were allegedly manufactured at facilities that have failed to meet standard safety and quality guidelines.

The FDA is particularly concerned that these illegally marketed, unapproved ophthalmic drug products pose a heightened risk of harm to users because drugs applied to the eyes bypass some of the body’s natural defenses, Food and Drug Administration, via statement.

The FDA is particularly concerned that these illegally marketed, unapproved ophthalmic drug products pose a heightened risk of harm to users because drugs applied to the eyes bypass some of the body’s natural defenses, Food and Drug Administration, via statement.

Gizmodo reports that the companies have 15 days to respond with their plans to correct the alleged violations.

If the companies fail to respond, the FDA could take further action to either seize or stop the manufacturing of the products in question.

When we identify illegally marketed, unapproved drugs and lapses in drug quality that pose potential risks, the FDA works to notify the companies involved of the violations, Jill Furman, Director of the Office of Compliance for the FDA’s Center for Drug Evaluation and Research, via Gizmodo.

We will continue to investigate potentially harmful eye products and work to ensure violative products stay off store shelves so that consumers can continue taking the medicines they need without concern, Jill Furman, Director of the Office of Compliance for the FDA’s Center for Drug Evaluation and Research, via Gizmodo.

We will continue to investigate potentially harmful eye products and work to ensure violative products stay off store shelves so that consumers can continue taking the medicines they need without concern, Jill Furman, Director of the Office of Compliance for the FDA’s Center for Drug Evaluation and Research, via Gizmodo


You Might Like


💡 newsR Knowledge: Other News Mentions

Food and Drug Administration Food and Drug Administration United States federal agency

The First Human Has Received Elon Musk’s Neuralink Brain Implant [Video]

The First Human Has Received Elon Musk’s Neuralink Brain Implant

The First Human Has Received , Elon Musk’s Neuralink Brain Implant. Musk took to X late on Jan. 29 to make the announcement, CNN reports. . The FDA cleared Neuralink for human clinical trials last year. The company recruited people with quadriplegia caused by either ALS or cervical spinal cord injury, CNN reports. . The trial is part of Neuralink's "PRIME Study," which stands for "Precise Robotically Implanted Brain-Computer Interface.". A robot installs the chip in the area of the brain responsible for the intention to move. . The chip then records brain signals and sends them to an app "to grant people the ability to control a computer cursor or keyboard using their thoughts alone," Neuralink said in September. Imagine if Stephen Hawking could communicate faster than a speed typist or auctioneer. That is the goal. , Elon Musk, via X. Other companies, such as Synchron, are also trying to develop brain-computer interfaces, CNN reports. . The idea of brain-nervous system interfaces has great potential to help people with neurological disorders in future. , Tara Spires-Jones, president of the British Neuroscience Association, via CNN. However, most of these interfaces require invasive neurosurgery and are still in experimental stages thus it will likely be many years before they are commonly available, Tara Spires-Jones, president of the British Neuroscience Association, via CNN

Credit: Wibbitz Top Stories    Duration: 01:31Published
Elon Musk's Neuralink implants brain chip in first human; ‘results promising’, says Musk | Oneindia [Video]

Elon Musk's Neuralink implants brain chip in first human; ‘results promising’, says Musk | Oneindia

The brain-chip startup Neuralink, founded by billionaire entrepreneur Elon Musk, achieved a major milestone over the weekend. The company successfully implanted its brain-computer interface (BCI) into the first human patient, marking a significant step forward in the field of neurotechnology. #Neuralink #ElonMusk #Telepathy #FDA #BrainChip #NeuralinkBrainChip ~PR.151~ED.101~

Credit: Oneindia    Duration: 02:43Published
Robitussin Products Recalled Nationwide [Video]

Robitussin Products Recalled Nationwide

Robitussin Products , Recalled Nationwide. Haleon, the manufacturer of Robitussin, is recalling the cough syrup because of a microbial contamination, 'The Hill' reports. . The recall was announced on Jan. 24. The products included in the recall are Robitussin Honey CF Max Day Adult and Robitussin Honey CF Max Adult. . According to Haleon, "the use of the affected product could potentially result in severe or life-threatening adverse events such as fungemia or disseminated fungal infection" in immunocompromised people. . In non-immunocompromised consumers, the population most likely to use the product, life-threatening infections are not likely to occur. , Haleon, Robitussin manufacturer, via statement. However, the occurrence of an infection that may necessitate medical intervention cannot be completely ruled out, Haleon, Robitussin manufacturer, via statement. Those in possession of these products are advised to halt consumption immediately. Haleon has also notified distributors, 'The Hill' reports. . If you've ingested the product and are experiencing problems, Haleon advises contacting your health care provider. The company also recommends reporting "adverse reactions or quality problems" to the FDA

Credit: Wibbitz Top Stories    Duration: 01:30Published
FDA Orders Drugmakers to Add Cancer Warning to CAR-T Treatments [Video]

FDA Orders Drugmakers to Add Cancer Warning to CAR-T Treatments

FDA Orders Drugmakers , to Add Cancer Warning to , CAR-T Treatments. This week, the Food and Drug Administration ordered drugmakers to add a warning to CAR-T cancer therapy, saying that the treatment may increase the risk of cancer. NBC reports that a spokesperson for the FDA said that despite the warning being ordered, , "the overall benefits of these products continue to outweigh their potential risks.". According to spokesperson Carly Kemper, the FDA's decision was prompted by reports of CAR-T patients developing rare forms of blood cancer. Kemper said that as of January 22, the agency had recorded 25 cases of CAR-T patients developing blood cancer. NBC reports that CAR-T, short for chimeric antigen receptor T cell, uses a patient's own immune cells to treat certain types of blood cancers. T cells are harvested, genetically altered to make them target cancer cells and then reinfused into the patient. . According to experts, the treatment has been highly effective in hard-to-treat cases. . This has been a game changer when we think about treating lymphoma and other diseases, Dr. Matthew Frigault, clinical director of the Massachusetts General Hospital Cellular Immunotherapy Program in Boston, via NBC. NBC reports that the first CAR-T therapy received FDA approval in 2017 with Novartis' drug, Kymriah. Another five drugs have since received FDA approval

Credit: Wibbitz Top Stories    Duration: 01:31Published

Gizmodo Gizmodo Design, technology, science, and science fiction website and blog

Apple Says Stop Putting Wet iPhones in Rice [Video]

Apple Says Stop Putting Wet iPhones in Rice

Apple Says Stop Putting , Wet iPhones in Rice. For years, smartphone users have relied on the rice soaking hack to save their drenched devices. The theory is that the dry rice draws moisture from the phone. But Apple is now officially advising people against this tactic, Gizmodo reports. . The tech company says that doing so can "allow small particles of rice to damage your iPhone.". Apple also advised against other hacks such as external heat sources or drying the connector with a cotton swab. Apple also advised against other hacks such as external heat sources or drying the connector with a cotton swab. Instead, the company recommends leaving your device unplugged and gently tapping it with your hand, connector side down. Leave your phone in a dry place with airflow and try charging again after 30 minutes. If you see an alert, there is still liquid in your phone and you should repeat the process. If your phone is dry but still won't charge, unplug the charger from the adapter and your wall, reconnect them and try again, Apple says.

Credit: Wibbitz Top Stories    Duration: 01:30Published
Amazon Prime Video Ads Are Here [Video]

Amazon Prime Video Ads Are Here

Amazon Prime , Video Ads Are Here. As of Jan. 29, Amazon Prime subscribers are being forced to pay another $3 per month if they'd like to watch content without ads, Gizmodo reports. The new monthly fee is in addition to the $139 a year Prime subscribers already pay. . The new monthly fee is in addition to the $139 a year Prime subscribers already pay. . According to Gizmodo, ads on Prime Video signify "the end of an era in streaming.". The implementation of the new structure means that the five biggest U.S. streaming services each have ads now. The last few years have seen Netflix, Disney+, Paramount+ and Max introduce ads as well. . Gizmodo reports that streamers can really only keep growing by raising subscription prices and introducing ads, so that's what they're doing. . Apple TV+ is one of the last major services that doesn't have ads, Gizmodo reports. As streaming becomes more costly and filled with advertisements, studios are investing less in additional content. . In 2023, Netflix produced 130 fewer shows compared to 2022, according to 'Bloomberg.'. Industry analysts report that competitors are taking a similar approach

Credit: Wibbitz Top Stories    Duration: 01:30Published
Google's DeepMind Pens 'Robot Constitution' to Govern Helper Robots [Video]

Google's DeepMind Pens 'Robot Constitution' to Govern Helper Robots

Google's DeepMind , Pens 'Robot Constitution' , to Govern Helper Robots. On January 4, Google announced a set of rules meant to govern the artificial intelligence system behind the company's intelligent machines. Gizmodo reports that the so-called 'Robot Constitution' is based on Isaac Asimov's 'Three Laws of Robotics.'. Gizmodo reports that the so-called 'Robot Constitution' is based on Isaac Asimov's 'Three Laws of Robotics.'. Before robots can be integrated into our everyday lives, they need to be developed responsibly with robust research demonstrating their real-world safety, Google DeepMind robotics team, via blog post. The 'Robot Constitution' was written by Google's DeepMind, the tech company's primary AI research wing. Google reportedly has plans for intelligent robots to soon help around homes and offices in the near future. These robotic helpers would run on a system of large language models (LLMs) and neural networks that would allow them to make decisions and be aware of their surroundings. Google says the 'Robot Constitution' is meant to act as part of a system of "layered safety protocols" which govern the machines that have already been deployed on the company's campus. DeepMind has currently deployed 52 unique robots that have performed 6,650 different tasks over the course of 77,000 robotic trials. Google's robot assistants are not allowed to accept tasks that involve humans, animals, sharp objects or electrical appliances. Gizmodo reports that the machines currently being tested by Google have only operated under the watchful eye of a human supervisor holding a physical kill switch.

Credit: Wibbitz Top Stories    Duration: 01:30Published